Develop New Diagnostic Suppliers In North America

Specific Diagnostics has developed in vitro diagnostic systems based upon a unique, patented metabolomic signature technology that enables rapid detection and identification of microorganisms as they grow in culture. Its first commercial application ...

We set out to completely redesign the arrhythmia monitor to elevate signal detection, comfort, and ease of use. Using feedback from patients, clinicians and physicians, we addressed the long-standing complaint in cardiac arrhythmia monitoring that ...

FYR Diagnostics is developing a powerful portfolio of biomarker detection technologies with a focus on nucleic acid amplification. Our mission is to commercialize and implement these novel technologies to enable the accelerated prediction, ...

Kephera Diagnostics is a startup that aims to address the public health challenges of global infectious diseases with point of care assay technology. We collaborate with a global community of researchers to develop and translate new technologies ...

Stelvio Oncology utilizes an image based method of epigenetic markers to develop predictive diagnostics and novel therapeutics for cancer. Stelvio Oncology is developing a personalized approach to glioblastoma treatment. Our team has core ...

MaxCyte. SeQure Dx, Inc. is applying state of the art genomics technologies for gene editor target profiling to advance discovery, clinical development, and diagnostic solutions. Our core technologies, GUIDE-seq and ONE-seq, enable identification of ...

Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and hospital acquired infections. Established in 1987, the company began research activity for ...

We are a Boston-based company developing precision diagnostics for infectious diseases. Selux’s interdisciplinary team has expertise in microbiology, biochemistry, chemistry, engineering, software, and algorithm design and is buttressed by ...

Diazyme uses its proprietary enzyme technologies to develop diagnostic reagents which can be used on most automated chemistry analyzers in user-friendly formats. Diazyme's products include test kits for diagnosis of cardiovascular disease, liver ...

Liferiver is a leading PCR-based molecular diagnostics solution provider, developing, manufacturing & marketing real time PCR diagnostic kits as well as instruments. We offer over 400 testing kits covering most infectious diseases, genetic diseases, ...

Chembio is a leading diagnostics company focused on developing and commercializing point-of-care tests used to detect and diagnose infectious diseases, including sexually transmitted disease, insect vector and tropical disease, COVID-19 and other ...

We are building a successful company based on powerful breakthrough science. We believe our efforts hold the potential to end cancer. We are determined to offer humanity a better life, free from cancer. While our goal is hugely ambitious, we are ...

The Genovis Group consists of Genovis AB, Sweden, and the wholly owned subsidiary Genovis Inc., USA. The company's shares are listed on Nasdaq First North Growth Market. Genovis’ business concept is to offer customers in the biopharmaceutical and ...

DiamiR is a privately held molecular diagnostics company focused on developing minimally invasive tests for detection and monitoring of pathology based on quantitative analysis of organ-enriched microRNA signatures in plasma for screening, patient ...

A champion of life sciences research for more than 30 years, IDT develops and manufactures nucleic acid products that support the life sciences industry. Areas of focus include academic and commercial research, agriculture, medical diagnostics, ...

More Diagnostics continues to introduce new controls, both with stabilized whole blood and human serum. The products are conceived in an on-site research and development department, and manufactured under stringent quality control criteria. The ...

By launching first-in-market biomarker tests and developing digital biomarkers for the continuous monitoring of disease, we support clinicians in their effort to provide exceptional care. Our technologies will empower clinician decision making and ...

Ellume is a digital diagnostics company that develops, manufactures, and commercializes high-performance, connected products for healthcare professionals and consumers. It is at the forefront of accurate, rapid and accessible testing that is ...

CG Research fills the gaps to develop your medical idea into a tangible product. We’ve worked with countless clients in various medical specializations, tailoring our development process to each client’s distinct needs and goals. No matter your ...

We are dedicated to one thing: improving outcomes for cancer patients. That’s why we focus on developing innovative diagnostic solutions that give patients and doctors the information they need—all from a simple blood test, known as a liquid biopsy. ...